Articles

Honoring the father of chemurgy, the award will be presented at the World Congress on Industrial Biotechnology and Bioprocessing in May.

Budget victories will help biotechnology in the Commonwealth

On March 9, the U.S. Senate Small Business and Entrepreneurship Committee voted 18-1 to pass the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Reauthorization Act of 2011 (S. 493). The bill includes provisions that would allow 25 percent of these grants to go to companies that are primarily backed by venture capital. The bill now goes to the full Senate. 

ISAAA data shows countries around the world have embraced agricultural biotechnology.

Bringing biotechs into global health R&D.

The Biotechnology Industry Organization (BIO) will hold its Intellectual Property Counsels Committee Spring Conference and Meeting in Seattle, Washington from April 13-15.

When you see “Get Your Flu Vaccine Here” signs and banners outside pharmacies and in doctor’s offices, you might think, “isn’t it too late for that?” The answer is no.

This month, BIO is leading a delegation of biopharma CEOs to China for meetings with members of the Chinese biotech community and government leaders. The mission illustrates a strong commitment on behalf of the western biotechnology industry to encourage China to strengthen its support for biotech innovation and take steps to enhance greater investment and collaboration with companies in China. The series of meetings between China’s local industry and government leaders and biotech CEOs will lay the foundation for increased cooperation to help biotech flourish in China.

Industry leaders point out that biotech-enabled advanced biofuels spur job growth and reduce U.S. dependence on imported oil.

Dr. Ferstenberg discusses an innovative program to guide small emerging biotech companies and how women in biotech can accelerate their leadership within the industry. 

Know someone who is using the power of biotechnology to heal, fuel or feed the planet?  Nominate them today for the Biotech Humanitarian Award!  BIO is currently seeking nominations for the Third Annual Biotech Humanitarian Award which will be presented at the 2011 BIO International Convention in Washington, DC, June 27- 30.

New listing requirements for proposed market would give more biotech companies option of going public.

The government’s Qualifying Therapeutic Discovery Project Program is doing what it was intended to do, according to a recent survey of senior executives at small biotechnology companies.

Scientific American will release the third annual Worldview: A Global Biotechnology Perspective at this year’s BIO International Convention.  Created in partnership with BIO, the publication explores the diverse economic regions of the world, highlighting success stories, policy achievements, cutting-edge science and the unique challenges that lie ahead. This year’s report focuses on BRIC (Brazil, Russia, India and China) country efforts to build local biotechnology hubs. 

Agency issues partial deregulation of Roundup Ready sugar beets while it prepares an environmental impact statement.

BIO review of this emerging science illustrates progress in applying synthetic biology to improve manufacturing processes.

For over a decade, agricultural biotechnology has provided solutions for the world's farmers in the form of plants that yield more per acre and reduce production costs while being resistant to disease and insect pests.

Farmers around the world continue to enthusiastically embrace genetically engineered (GE) crops according to the ISAAA report for 2009.

Learn the key terms associated with agricultural biotechnology.

Learn more about the history of biotechnology.

Personalized medicine has the potential to revolutionize patient care. The fundamental goal in advancing our healthcare system through personalized medicine is to deliver the right treatment to the right patient at the right time.

A report by Health Advances found that significant limitations in the current reimbursement system for novel diagnostics lead to inconsistent coverage decisions and impede the investment necessary for the development of the next generation of diagnostics.

 

Agricultural Economics

A bioeconomy is one built upon renewable biofuels, bio-based chemicals and bio-based materials. In a bioeconomy, experts can replace energy and materials as fast as society uses them. As the population continues to grow and put greater demands on the food and energy supply, a sustainable bioeconomy model is necessary to ensure that society can continue to feed and fuel its members.

 

Biofeedstocks and Biomass